Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Identifying central sensitization in adults with sickle cell disease: Differences in clinical features and psychobehavioral factors
source: The Journal of Pain
year: 2015
authors: G. Moscou-Jackson, C. Campbell, P. Finan, C. Carroll, S. Lanzkron, C. Haywood Jr., J. Haythornthwaite
summary/abstract:Central sensitization (CS) has been identified as a leading culprit responsible for maintaining pain in several chronic pain conditions. It may explain differences in the symptom experience of individuals with Sickle Cell Disease (SCD). Quantitative sensory testing (QST) can be used to examine CS and identify individuals that may have a heightened CS profile. The present study identified and categorized SCD patients based on QST into a high or low CS phenotype and examined clinical pain, vaso-occlusive crises, psychosocial factors, and sleep continuity (i.e. sleep duration, sleep fragmentation, and sleep efficiency) differences between groups.
Thirty-four (34) adults with SCD who completed daily morning (sleep) and evening (pain) diaries over a three-month period and underwent QST were included in these analyses. Participants were divided into CS groups (i.e. No/Low CS vs. High CS), based on thermal and mechanical temporal summation and after-sensations, which were norm-referenced to healthy, matched controls. Sixteen participants exhibited No or Low CS while 18 exhibited High CS. Participants in the High CS group were significantly older (mean age 43.5 years vs. 33.9 years, p = 0.02), but there was no significant difference in sex between groups.
During the average of 74 days of diary monitoring, participants in the High CS group on average experienced significantly higher clinical pain (mean difference = 24.0/100 points), more vaso-occlusive crises (mean difference = +15%), more catastrophizing, greater negative mood, and poorer sleep continuity (p’s <0.05), however, there was no difference in sleep duration between groups (p = 0.78).We demonstrated individual differences in central pain processing among individuals with SCD. In general, greater central sensitization was associated with higher clinical pain, more crises, worse sleep, and more psychosocial disturbances. Future analyses should investigate whether sleep and psychosocial disturbances mediate the relationship between central sensitization and pain outcomes.
organization: Johns Hopkins University School of Nursing, Baltimore, MDDOI: 10.1016/j.jpain.2015.01.138
read more
Related Content
-
Pharmacogenetics for Safe Codeine Use in Sickle Cell DiseaseAfter postoperative deaths in children w...
-
GBT expands sickle cell disease pipeline with worldwide licensing agreement for inclacumab for the treatment of vaso...Global Blood Therapeutics, Inc...
-
Increased acute care utilization in a prospective cohort of adults with sickle cell diseaseThe ESCAPED (Examining Sickle Cell Acute...
-
Vaso occlusive Crisis Pain Assessment & Managementhttps://www.youtube.com/watch?time_conti...
-
More Online Queries in Winter Suggest Seasonal Variations in SCD ActivityMore people search for information on si...
-
New Guidelines for Managing Sickle Cell Disease Presented at ACP Internal Medicine MeetingNew guidelines for therapeutic strategie...
-
CTX001 Continues to Show Promise in Severe SCDA single dose of CTX001, an experimental...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.